🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢La Agencia Europea de Medicamentos EU Medicines Agency he emitido una recomendación positiva sobre la autorización de comercialización de lecanemab en Europa, un fármaco que ralentiza el progreso de la enfermedad de #Alzheimer en sus primeras fases. fpmaragall.org/noticias/la-em…

🗨️Marc Suárez-Calvet 🧠🧪 🩺🌈, neurólogo de Fundación Pasqual Maragall: "Es importante destacar que esta recomendación no implica una disponibilidad inmediata del fármaco en toda Europa, ya que cada país deberá decidir si se incluye en su sistema de salud pública" sciencemediacentre.es/la-ema-revisa-…

Please share! Great opportunity in an amazing environment.

New study compares plasma #biomarkers for detecting #Alzheimer’s disease in memory clinics The plasma p-tau biomarkers demonstrated superior accuracy in detecting Alzheimer's compared to other biomarkers #Neurologia Barcelonaβeta Brain Research Center HMar Research Institute hospitaldelmar.cat/en/noticies/vi…

Using data from 1,767 patients across 5 medical centers, researchers validated Lumipulse p-tau217—an automated, scalable system with an accuracy in hospital settings over 90%, comparable to that of a lumbar puncture. barcelonabeta.org/en/news/news/b…

🔴 Ja es pot diagnosticar l'Alzheimer amb una analítica "El neuròleg fa diverses proves i una que ens pot ajudar pot ser aquest biomarcador en sang, que sempre ha d'interpretar l'especialista", Marc Suárez-Calvet, investigador Hospital del Mar i Fundación Pasqual Maragall #TotEsMou3Cat

Buscamos neurólogos/as para unirse a Barcelonaβeta Brain Research Center Fundación Pasqual Maragall 🧠👩🏻‍⚕️ ➡️estudios observacionales, ensayos clínicos ➡️investigación (con opciones de PhD y postdoc), ➡️actividad clínica en Hospital del Mar Aplica en el enlace👇 barcelonabeta.org/es/centro-inve…

Lecanemab has been approved in Europe—the first disease-modifying treatment for #Alzheimer . Now, from public health centers, we must ensure equitable access, minimize risks, and offer the best care. 🧠🏥💚 Barcelonaβeta Brain Research Center Fundación Pasqual Maragall Hospital del Mar ec.europa.eu/newsroom/sante…

🚨 The European Commission has officially approved #lecanemab as a treatment for early-stage Alzheimer's disease. This marks a major milestone in tackling the disease at its root. ⤵️📰 barcelonabeta.org/en/news/news/e…

New paper out! A new study led by researchers at the #BBRC highlights the potential of a blood-based biomarker panel to detect early signs of Alzheimer’s disease in middle-aged individuals with no evident cognitive symptoms. barcelonabeta.org/en/news/news/n…